Royalty Reduction. If Medical School grants additional licenses to third parties pursuant to Section 3.1., the royalty rates set forth in Subsection 4.5.(a) shall be adjusted, if necessary, so as not to exceed the royalty rates charged any other licensee of the Patent Rights during the term of the non-exclusive license.
Appears in 21 contracts
Sources: Exclusive License Agreement (Cytrx Corp), License Agreement (Rxi Pharmaceuticals Corp), Exclusive License Agreement (Cytrx Corp)
Royalty Reduction. If Medical School grants and ABL grant additional licenses to third parties pursuant to Section 3.1., the royalty rates set forth in Subsection 4.5.(a) shall be adjusted, if necessary, so as not to exceed the royalty rates charged any other licensee of the Patent Rights during the term of the non-exclusive license.
Appears in 1 contract